LPL Financial
HOWL icon

LPL Financial’s Werewolf Therapeutics HOWL Stock Holding History

LPL Financial’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.24K Buy
11,791
+1,791
+18% +$1.09K ﹤0.01% 6192
2026
Q1 		$8.33K Buy
+10,000
New +$6.85K ﹤0.01% 5933

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial's HOWL Position: Q2 2026 in Review

LPL Financial increased its Werewolf Therapeutics (HOWL) stake by 18% in Q2 2026, buying an estimated $1.09K and bringing the position to 11,791 shares worth $4.24K. The position accounts for ﹤0.01% of the portfolio, ranked #6192.

LPL Financial first reported a position in HOWL in Q1 2026 and has held it in 2 quarters since. The position peaked at $8.33K in Q1 2026. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

  • LPL Financial held 11,791 shares of Werewolf Therapeutics worth $4.24K as of Q2 2026.
  • LPL Financial bought 1,791 Werewolf Therapeutics shares in Q2 2026, an estimated $1.09K.
  • Werewolf Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6192 holding.
  • LPL Financial first reported a position in Werewolf Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • LPL Financial's Werewolf Therapeutics position peaked at $8.33K in Q1 2026.
  • 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.